<DOC>
	<DOCNO>NCT00300846</DOCNO>
	<brief_summary>The purpose study evaluate effect patient weight adjunctive therapy aripiprazole clozapine versus clozapine monotherapy , schizophrenic patient optimally control clozapine .</brief_summary>
	<brief_title>A Study Adjunctive Treatment Aripiprazole Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Patients schizophrenia treat clozapine ( 200900 mg/day ) , gain least 2.5 kg clozapine . Patients know allergic aripiprazole Hospitalized patient Patients previously receive study medication aripiprazole clinical study participate clinical trial investigational agent within past month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>